Concepedia

Sarah Williams

SW

20

Publications

2.1K

Citations

16

H-Index

1994

Active since

Affiliations

Novartis (United States)(Current)

Novartis (Switzerland)

Novartis Institutes for BioMedical Research

University of Cincinnati Medical Center

University of California San Diego

Sarah Williams is an author at Novartis (United States) specializing in medicine, cell biology, and natural sciences.

ORCID

Top concepts

Publications per year

1994–2023

20

Publications

20

Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases

Ying-Nan P. Chen, Matthew J. LaMarche, Ho Man Chan et al. · Nature · 2016 · 893 citations

, , +12

Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor

Jorge Fortanet, Christine Hiu-Tung Chen, Ying-Nan P. Chen et al. · Journal of Medicinal Chemistry · 2016 · 284 citations · Full text

, , +20

Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer

Matthew J. LaMarche, Michael Acker, Andreea Argintaru et al. · Journal of Medicinal Chemistry · 2020 · 207 citations · Full text

Dual Allosteric Inhibition of SHP2 Phosphatase

Michelle Fodor, Edmund V. Price, Ping Wang et al. · ACS Chemical Biology · 2018 · 127 citations · Full text

Unbiased analysis of RB-mediated transcriptional repression identifies novel targets and distinctions from E2F action.

Michael Markey, Steven P. Angus, Matthew W. Strobeck et al. · PubMed · 2002 · 122 citations

, , +21

Rows per page

1–5 of 20